SUBSCRIBE
SUBSCRIBE
News   FDA

AstraZeneca PLC’s Plavix Rival Brilique Wins EU Approval

December 6, 2010 | 
1 min read
LONDON, Dec 6 (Reuters) - AstraZeneca's (AZN.L) new heart medicine Brilique -- or Brilinta -- won final clearance from EU regulators on Monday, putting it on track to compete with Plavix, the world's second biggest-selling drug, next year.
FDA Approvals Europe
AstraZeneca Pharmaceuticals LP
MORE ON THIS TOPIC
Close-Up Of Syringe With Bottles Against Blue Background
RSV
Kennedy Follows RSV Recommendations of ACIP Members He Fired
July 3, 2025
 · 
3 min read
 · 
Tristan Manalac
Minimal icon featuring open blue padlock with white upward arrow passing through it, symbolizing security, access, or unlocking new opportunities, digital access, data protection, 3d rendering
Accelerated approval
Regeneron Scores Multiple Myeloma Nod for Bispecific, Unlocking $600M Opportunity
July 3, 2025
 · 
2 min read
 · 
Tristan Manalac
Megaphone with stethoscope isolated on orange background. 3d illustration
Women’s health
Biotech Leaders, Investors Ask FDA to Maintain Access to Mifepristone
July 3, 2025
 · 
2 min read
 · 
Tristan Manalac
Yellow warning sign symbol or alert safety danger caution illustration icon security message and exclamation triangle information icon on attention traffic background with secure alarm. 3D render.
Regulatory
FDA Mulls ‘Regulatory Action’ on Argenx’s Vyvgart Hytrulo Over Severe Safety Concerns
July 2, 2025
 · 
2 min read
 · 
Tristan Manalac